Other

Klz Holdings, LLC

Velocity Life Sciences, LLC

Bruce W Kneller

Hector L Lopez

Tim N Ziegenfuss

Timothy N Ziegenfuss

Brandon S Sojka

Ronald Kramer

Alexander Nikolaidis

A food product comprises L-lysine butyrate. The food product does not contain gluten and is not a baked product. Alternatively, the product is an oral dosage form comprising 25 mg to 5.0 g L-lysine butyrate. The oral dosage form is a tablet, a capsule, or a sealed packet containing powder. In another alternative, orally administering L-lysine butyrate may be used to: supplementing butyrate, provide a nootropic effect, treat a condition, losing weight, improve cognition, induce or maintain ketosis, improve athletic performance, or treat or mitigate mild-to-moderate pain.

Compositions containing short-chain fatty acid, methods of use, and methods of making thereof

The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound. The present invention also relates to a diluent for parenteral compounds. The diluent comprises palatinose or a derivative thereof. Another aspect of the present invention is directed to a method of decreasing the recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose, or a derivative thereof, to the mammal. The present invention is further directed to a method of supplying a compound to a diabetic patient, burn victim patient or trauma victim patient. The method comprises administering palatinose, or a derivative thereof, in combination with the compound.

Palatinose for enhancing dietary supplement and pharmaceutical delivery

Compositions and methods include a synergistically effective combination of glycerol andextract for increasing muscle volume in response to an exercise stimulus of the corresponding muscle or muscle region.

Compositions and methods for increase in muscle volume

The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound. The present invention also relates to a diluent for parenteral compounds. The diluent comprises palatinose or a derivative thereof. Another aspect of the present invention is directed to a method of decreasing the recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose or a derivative thereof, to the mammal. The present invention is further directed to a method of supplying a compound to a diabetic patient, burn victim patient or trauma victim patient. The method comprises administering palatinose, or a derivative thereof, in combination with the compound.

Disclosed are salts of 2-phenylethylamines and deprotonated inorganic acids, compositions and formulations containing the same, and methods of making and using the salts, compositions and formulations.

Salts of phenylethylamines and inorganic acids and methods of use thereof

The invention relates to compositions (e.g., nutritional supplements) comprising, consisting essentially of, or consisting of a creatine bicarbonate, and to methods of making and using said compositions.

Compositions comprising creatine salts and methods of use thereof

A composition having at least one modified or derivative of 1,4,6-androstatriene-3,17-dione ('ATD') will improve the health of mammalian subjects. The improvement of health is achieved with the administration of an effective amount of at least one modified or derivative of 1,4,6-androstatriene-3,17-dione. Particularly, health is improved for a subject suffering with a gynecomastia and/or estrogen-dependent cancer. Also, subjects recovering from steroid misuse/abuse will benefit from treatment in accordance with the present invention.

Growing community of inventors

Howell, NJ, United States of America

Bruce W Kneller